Summary
“The Digital Health Center of Excellence was hit pretty heavy, and also AI researchers at OSEL. I am not too worried about PCCP but the impact could be on how quickly FDA can finalize the other draft guidance with larger scope applied to all medical devices.”
In this episode of the Let's Talk Risk Podcast, Naveen Agarwal and Yu Zhao discuss the P…
Listen to this episode with a 7-day free trial
Subscribe to Let's Talk Risk! to listen to this post and get 7 days of free access to the full post archives.
